patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Letter to shareholders

Industry Leadership

  • ''We have been working with the Alliance for Regenerative Medicine (ARM), an industry organization, to help bring about a legislative, funding, and reimbursement environment that can accelerate the commercialization of breakthrough cell therapies which have the potential to transform the lives of patients in need. In April, our executives met with members of congress to generate bipartisan support for bills in the Senate and House of Representatives that promote the value of regenerative medicine.''

IMO Hope for making real money here before 2 more yrs ---

baring any astounding trial developments

Give us back compassionate last death efforts - pls

this smacks at it

Or lets get to heart of the matter - That give it some real muscle.... todamoon

try altimzrs

e

Share
New Message
Please login to post a reply